NexImmune Company
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Technology:
Atrificial Vectors and Immune Cells, Cell-based gene therapy
Industry:
Atrificial Vectors and Immune Cells, Public
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
7
Total Funding:
210268293
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-02-17
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership